SIRPA and cancer: To determine the impact of MSC CD47 or PD-L1 expression on macrophage phagocytosis, we repeated the cancer cell phagocytosis assay (Figure 8D) with the addition of SIRP-α and PD-1 receptor-blocking antibodies.